cysteamine has been researched along with l 365260 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ewing, RW; Fitzpatrick, LR; Martin, GE; Molino, BF; Pendley, CE | 1 |
| Hayashi, N; Ikeda, M; Shimizu, K; Shiratori, K; Watanabe, S | 1 |
| Impicciatore, M; Letari, O; Makovec, F; Mennuni, L; Revel, L | 1 |
3 other study(ies) available for cysteamine and l 365260
| Article | Year |
|---|---|
The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
Topics: Animals; Aspirin; Benzodiazepinones; Cysteamine; Digestive System; Dose-Response Relationship, Drug; Ethanol; Gastric Acid; Guinea Pigs; In Vitro Techniques; Male; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin | 1993 |
Evidence for a significant role of gastrin in cysteamine-induced hypersecretion of gastric acid.
Topics: Animals; Atropine; Benzodiazepinones; Cysteamine; Gastric Acid; Gastric Mucosa; Gastrins; Immune Sera; Male; Phenylurea Compounds; Rabbits; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1997 |
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Calcium; Cats; Chronic Disease; Cysteamine; Dose-Response Relationship, Drug; Ethanol; Gastric Acid; Gastric Fistula; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Perfusion; Phenylurea Compounds; Rabbits; Ranitidine; Rats; Receptors, Cholecystokinin; Stomach; Stomach Ulcer | 1999 |